Gemphire Therapeutics | 4:持股变动声明
Gemphire Therapeutics | 3:首次持股声明
Gemphire Therapeutics | 8-K:重大事件
Gemphire Therapeutics | 10-Q:2020财年二季报
Gemphire Therapeutics | 8-K:重大事件
Gemphire Therapeutics | 15-12G:终止注册
Gemphire Therapeutics | S-8 POS:员工福利计划证券登记(修正)
Gemphire Therapeutics | UPLOAD:其他
Gemphire Therapeutics | UPLOAD:其他
Gemphire Therapeutics | CORRESP:信函
Gemphire Therapeutics | 6-K:外国发行人报告
Gemphire Therapeutics | 25:注销已到期、已赎回、已兑付证券的通知
Gemphire Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)
Gemphire Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)
Gemphire Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)
Gemphire Therapeutics | CB/A:合并或股权增发(修正)
Gemphire Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)
Gemphire Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)
Gemphire Therapeutics | CB/A:合并或股权增发(修正)
Gemphire Therapeutics | CB/A:合并或股权增发(修正)